ThePrintPod: Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance

ThePrint

19-12-2024 • 5 mins

Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.

You Might Like

The Morning Brief
The Morning Brief
The Economic Times
ANI Podcast with Smita Prakash
ANI Podcast with Smita Prakash
Asian News International (ANI)
Global News Podcast
Global News Podcast
BBC World Service
ThePrint
ThePrint
ThePrint
Top of the Morning
Top of the Morning
Mint - HT Smartcast
Economist Podcasts
Economist Podcasts
The Economist
FT News Briefing
FT News Briefing
Financial Times
Daybreak
Daybreak
The Ken
The Daily
The Daily
The New York Times
WSJ What’s News
WSJ What’s News
The Wall Street Journal
The Journal.
The Journal.
The Wall Street Journal & Gimlet
HT Daily News Wrap
HT Daily News Wrap
Hindustan Times - HT Smartcast
WSJ Tech News Briefing
WSJ Tech News Briefing
The Wall Street Journal
The Cārvāka Podcast
The Cārvāka Podcast
The Cārvāka Podcast